TTTP president, Carol Slavin, stated, "The acquisition of H. Bana gives TTTP an entrée into the lucrative hair regrowth market segment. We believe consumers are always anxious to utilize naturally occurring alternatives to pharmaceutical drugs with their attendant costs of visits to physicians and high mark-ups on patented medicines. The Hinoki Bana product, applied topically, underwent extensive clinical trials in June of 2000 demonstrating the products as efficacious with a 92% satisfaction rate among both men and women participants." TTTP plans a targeted 3rd quarter 2004 rollout for Hinoki Bana natural hair regrowth products.

Today's $6.5 billion vitamins, minerals, and neutraceuticals markets' growth potential is projected to surpass $20 billion in retail sales by year 2007. According to market research, supplements will dominate the surging vitamin and minerals market. Chain drug store pharmacies are forecast to account for more than 50 percent of this category volume as physicians and pharmacists nationwide are fueling the direction toward alternative therapy.

The Markets

Although vitamins are the leading category, specialty supplements are driving growth; 2000 sales of specialty dietary supplements were roughly $1.65 billion. The compound average growth rate for specialty supplements from 1995 to 2000 was 18.7 percent, far outpacing growth in the overall supplement market.

SPINS, a San Francisco-based market research firm, in conjunction with A.C. Nielsen, states retail sales of specialty supplements through mainstream stores and natural supermarkets to be roughly $551 million in the 12 month period from June 2000 through May 2001. Future sales growth is likely to come from the migration of occasional to regular users of dietary supplements, suggests Health Business Partners.

In a report by researcher Frost & Sullivan, consumers' continuing desire to maintain their own health and appearance without the use of synthetic drugs has led to an explosion in sales of natural dietary supplements. Increasing scientific evidence supports the growth of this trend says Frost & Sullivan. The report goes on to state that the US natural dietary supplements market generated revenues of $6.67billion in 2000. Frost & Sullivan projects this figure to top $21 billion by 2007.

According to AC Nielsen sales of acne remedies in the drug, mass and supermarket channels reached $343 million in the 52-week period ended May 19, 2001. The medicated skin care market increased 7.9% in food channels with sales in excess of $88 million; 12.7% at drug stores bumping sales to about $95 million and experienced a 16.8% gain at mass merchants where sales exceed $120 million. The international market for acne remedies is estimated at another $400 million, bringing the total potential market to around $800 million worldwide.

Chain drug store pharmacies are forecast to account for more than 50 percent of this category volume as physicians and pharmacists nationwide are fueling the direction toward alternative therapy.12 to 20 Plus has begun to build its Anaplex™ brand with distribution in Longs Drug Stores, a recognized leader in the chain drug industry trading on the NYSE.

12 to 20 Plus, Inc. has spent years in the research and development of a "spa style" acne therapy system™. Utilizing a high tech with natural overtones product development technology, the system delivers sensitive, but powerful treatment. One of the products is Zit Stick®, an on-the-go medication. The market for acne remedies, which are always in demand, in the drug, mass and supermarket channels, is expected to reach $370 million in 2004.

Its Neurochemical Research Group (NRG) division markets highly effective condition-specific dietary supplements containing the most sophisticated combination of extensively researched nutritional elements available. The products, manufactured by FDA-approved labs, do not contain herbs. The Company utilizes potent pharmaceutical grade "amino acids," important protein constituents that serve as neurotransmitter precursors, membrane stabilizers and enzyme precursors. For energy production and other body functions, the utilization of amino acids is improved by providing the proper nutrients, such as antioxidants to support their activities.

Marketing research, product development, Beta testing and various mergers and acquisitions in 2003, has now positioned 12 to 20 Plus to roll out its full product line of preventative health care products into the multi-billion dollar Over the Counter (OTC) market. 12 To 20 Plus is ready to capitalize on its exceptional product line.

Proprietary Formulae and Web site: www.neurochemicalresearch.com.

QuitSystem® neuronutrient supplementation for recovery from alcohol, drugs and smoking.

Anaplex™, the antidepressant drug alternative.

VisionKare™, advanced supplement for macular degeneration.

Trim-A-Way®, body shaper supplements.

Male Virility™ natural alternative to Viagra.

This press release contains forward-looking statements about events and circumstances that have not yet occurred. For example, words such as "will," "can," "expects," "enables," "believes" or other statements in the future tense, are forward-looking statements. Actual outcomes and results may differ materially from expectations in this press release due to a number of risks and uncertainties. Such risks and uncertainties include whether the market for 12 to 20 Plus products will grow as projected, if at all, whether demand for OTC products will continue as forecasted. I R Contact: Venture Capital Resource, Ltd. at 775-827-4557, or vencapltd@sbcglobal.net. Attn: Jay Smith.

I R Contact:
Jay Smith
Venture Capital Resource, Ltd.
775-827-4557
vencapltd@sbcglobal.net.